nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—SLC15A2—melanoma	0.772	1	CbGaD
Trandolapril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00688	0.233	CbGpPWpGaD
Trandolapril—ACE—umbilical vein—melanoma	0.00577	0.145	CbGeAlD
Trandolapril—ACE—hindlimb—melanoma	0.00528	0.133	CbGeAlD
Trandolapril—ACE—arm—melanoma	0.00504	0.127	CbGeAlD
Trandolapril—ACE—appendage—melanoma	0.00453	0.114	CbGeAlD
Trandolapril—ACE—endothelium—melanoma	0.00273	0.0687	CbGeAlD
Trandolapril—CES1—neck—melanoma	0.00271	0.0681	CbGeAlD
Trandolapril—ACE—blood vessel—melanoma	0.00252	0.0633	CbGeAlD
Trandolapril—ACE—neck—melanoma	0.0018	0.0453	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—XRCC3—melanoma	0.00159	0.0538	CbGpPWpGaD
Trandolapril—SLC15A1—mammalian vulva—melanoma	0.00149	0.0373	CbGeAlD
Trandolapril—ACE—eye—melanoma	0.00134	0.0337	CbGeAlD
Trandolapril—CES1—NRF2 pathway—SLC39A12—melanoma	0.00116	0.0394	CbGpPWpGaD
Trandolapril—SLC15A2—retina—melanoma	0.00116	0.0291	CbGeAlD
Trandolapril—CES1—head—melanoma	0.00114	0.0288	CbGeAlD
Trandolapril—ACE—mammalian vulva—melanoma	0.00106	0.0267	CbGeAlD
Trandolapril—Fosinopril—SLC15A2—melanoma	0.00105	0.129	CrCbGaD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000962	0.0326	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—TRRAP—melanoma	0.00093	0.0315	CbGpPWpGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.000927	0.0314	CbGpPWpGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000893	0.0302	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—APC—melanoma	0.000876	0.0297	CbGpPWpGaD
Trandolapril—Perindopril—SLC15A2—melanoma	0.000852	0.105	CrCbGaD
Trandolapril—Spirapril—SLC15A2—melanoma	0.000843	0.104	CrCbGaD
Trandolapril—Moexipril—SLC15A2—melanoma	0.000808	0.0995	CrCbGaD
Trandolapril—CES1—lymph node—melanoma	0.000802	0.0201	CbGeAlD
Trandolapril—ACE—head—melanoma	0.000762	0.0191	CbGeAlD
Trandolapril—Quinapril—SLC15A2—melanoma	0.000751	0.0925	CrCbGaD
Trandolapril—Cilazapril—SLC15A2—melanoma	0.000751	0.0925	CrCbGaD
Trandolapril—CES1—Fluoropyrimidine Activity—SMUG1—melanoma	0.000751	0.0254	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—TP73—melanoma	0.00075	0.0254	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—MCL1—melanoma	0.00075	0.0254	CbGpPWpGaD
Trandolapril—Ramipril—SLC15A2—melanoma	0.000727	0.0896	CrCbGaD
Trandolapril—SLC15A2—head—melanoma	0.000664	0.0167	CbGeAlD
Trandolapril—Benazepril—SLC15A2—melanoma	0.000653	0.0804	CrCbGaD
Trandolapril—CES1—E2F transcription factor network—APAF1—melanoma	0.0006	0.0203	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—EPHA2—melanoma	0.000568	0.0193	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000566	0.0192	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—ERCC2—melanoma	0.000559	0.0189	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000546	0.0185	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC6A11—melanoma	0.000534	0.0181	CbGpPWpGaD
Trandolapril—ACE—lymph node—melanoma	0.000533	0.0134	CbGeAlD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000526	0.0178	CbGpPWpGaD
Trandolapril—SLC15A2—lymph node—melanoma	0.000465	0.0117	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—PAX6—melanoma	0.000455	0.0154	CbGpPWpGaD
Trandolapril—Mitiglinide—PPARG—melanoma	0.000423	0.052	CrCbGaD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000399	0.0135	CbGpPWpGaD
Trandolapril—Nateglinide—SLC15A2—melanoma	0.000376	0.0463	CrCbGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000371	0.0126	CbGpPWpGaD
Trandolapril—Cardiac failure—Docetaxel—melanoma	0.000357	0.00237	CcSEcCtD
Trandolapril—Pruritus—Vemurafenib—melanoma	0.000356	0.00237	CcSEcCtD
Trandolapril—Connective tissue disorder—Temozolomide—melanoma	0.000356	0.00237	CcSEcCtD
Trandolapril—Urethral disorder—Temozolomide—melanoma	0.000355	0.00236	CcSEcCtD
Trandolapril—Alopecia—Dactinomycin—melanoma	0.000354	0.00235	CcSEcCtD
Trandolapril—Eye disorder—Carmustine—melanoma	0.00035	0.00233	CcSEcCtD
Trandolapril—Hyponatraemia—Docetaxel—melanoma	0.000349	0.00232	CcSEcCtD
Trandolapril—Visual impairment—Temozolomide—melanoma	0.000349	0.00232	CcSEcCtD
Trandolapril—Pain in extremity—Docetaxel—melanoma	0.000348	0.00232	CcSEcCtD
Trandolapril—Flushing—Carmustine—melanoma	0.000348	0.00231	CcSEcCtD
Trandolapril—Ill-defined disorder—Bleomycin—melanoma	0.000347	0.00231	CcSEcCtD
Trandolapril—Anaemia—Bleomycin—melanoma	0.000345	0.0023	CcSEcCtD
Trandolapril—Diarrhoea—Vemurafenib—melanoma	0.000344	0.00229	CcSEcCtD
Trandolapril—Migraine—Docetaxel—melanoma	0.000342	0.00228	CcSEcCtD
Trandolapril—Erythema multiforme—Temozolomide—melanoma	0.000342	0.00228	CcSEcCtD
Trandolapril—Eye disorder—Temozolomide—melanoma	0.000338	0.00225	CcSEcCtD
Trandolapril—Tinnitus—Temozolomide—melanoma	0.000337	0.00225	CcSEcCtD
Trandolapril—Malaise—Bleomycin—melanoma	0.000337	0.00224	CcSEcCtD
Trandolapril—Cardiac disorder—Temozolomide—melanoma	0.000336	0.00224	CcSEcCtD
Trandolapril—Flushing—Temozolomide—melanoma	0.000336	0.00224	CcSEcCtD
Trandolapril—Arrhythmia—Carmustine—melanoma	0.000335	0.00223	CcSEcCtD
Trandolapril—Leukopenia—Bleomycin—melanoma	0.000334	0.00223	CcSEcCtD
Trandolapril—Dizziness—Vemurafenib—melanoma	0.000333	0.00221	CcSEcCtD
Trandolapril—Alopecia—Carmustine—melanoma	0.000331	0.0022	CcSEcCtD
Trandolapril—Angiopathy—Temozolomide—melanoma	0.000328	0.00219	CcSEcCtD
Trandolapril—Mental disorder—Carmustine—melanoma	0.000328	0.00218	CcSEcCtD
Trandolapril—Immune system disorder—Temozolomide—melanoma	0.000327	0.00218	CcSEcCtD
Trandolapril—Mediastinal disorder—Temozolomide—melanoma	0.000326	0.00217	CcSEcCtD
Trandolapril—Malnutrition—Carmustine—melanoma	0.000326	0.00217	CcSEcCtD
Trandolapril—Cough—Bleomycin—melanoma	0.000326	0.00217	CcSEcCtD
Trandolapril—Ill-defined disorder—Dactinomycin—melanoma	0.000323	0.00215	CcSEcCtD
Trandolapril—Anaemia—Dactinomycin—melanoma	0.000322	0.00214	CcSEcCtD
Trandolapril—Liver function test abnormal—Docetaxel—melanoma	0.000321	0.00214	CcSEcCtD
Trandolapril—Vomiting—Vemurafenib—melanoma	0.00032	0.00213	CcSEcCtD
Trandolapril—Alopecia—Temozolomide—melanoma	0.00032	0.00213	CcSEcCtD
Trandolapril—Dry skin—Docetaxel—melanoma	0.000319	0.00212	CcSEcCtD
Trandolapril—Chest pain—Bleomycin—melanoma	0.000318	0.00212	CcSEcCtD
Trandolapril—Myalgia—Bleomycin—melanoma	0.000318	0.00212	CcSEcCtD
Trandolapril—Rash—Vemurafenib—melanoma	0.000317	0.00211	CcSEcCtD
Trandolapril—Mental disorder—Temozolomide—melanoma	0.000317	0.00211	CcSEcCtD
Trandolapril—Dermatitis—Vemurafenib—melanoma	0.000317	0.00211	CcSEcCtD
Trandolapril—Back pain—Carmustine—melanoma	0.000315	0.0021	CcSEcCtD
Trandolapril—Headache—Vemurafenib—melanoma	0.000315	0.0021	CcSEcCtD
Trandolapril—Malnutrition—Temozolomide—melanoma	0.000315	0.0021	CcSEcCtD
Trandolapril—Breast disorder—Docetaxel—melanoma	0.000314	0.00209	CcSEcCtD
Trandolapril—Discomfort—Bleomycin—melanoma	0.000314	0.00209	CcSEcCtD
Trandolapril—Malaise—Dactinomycin—melanoma	0.000314	0.00209	CcSEcCtD
Trandolapril—Cramp muscle—Docetaxel—melanoma	0.000313	0.00209	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000313	0.00209	CcSEcCtD
Trandolapril—Leukopenia—Dactinomycin—melanoma	0.000312	0.00208	CcSEcCtD
Trandolapril—Dysgeusia—Temozolomide—melanoma	0.000309	0.00205	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Docetaxel—melanoma	0.000307	0.00204	CcSEcCtD
Trandolapril—Oedema—Bleomycin—melanoma	0.000305	0.00203	CcSEcCtD
Trandolapril—Back pain—Temozolomide—melanoma	0.000305	0.00203	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—E2F1—melanoma	0.000305	0.0103	CbGpPWpGaD
Trandolapril—Infection—Bleomycin—melanoma	0.000303	0.00202	CcSEcCtD
Trandolapril—Anaemia—Carmustine—melanoma	0.000301	0.00201	CcSEcCtD
Trandolapril—Agitation—Carmustine—melanoma	0.0003	0.00199	CcSEcCtD
Trandolapril—Nausea—Vemurafenib—melanoma	0.000299	0.00199	CcSEcCtD
Trandolapril—Thrombocytopenia—Bleomycin—melanoma	0.000298	0.00199	CcSEcCtD
Trandolapril—Myalgia—Dactinomycin—melanoma	0.000297	0.00197	CcSEcCtD
Trandolapril—Discomfort—Dactinomycin—melanoma	0.000293	0.00195	CcSEcCtD
Trandolapril—Angina pectoris—Docetaxel—melanoma	0.000293	0.00195	CcSEcCtD
Trandolapril—Ill-defined disorder—Temozolomide—melanoma	0.000292	0.00195	CcSEcCtD
Trandolapril—Leukopenia—Carmustine—melanoma	0.000292	0.00194	CcSEcCtD
Trandolapril—Anaemia—Temozolomide—melanoma	0.000291	0.00194	CcSEcCtD
Trandolapril—Anorexia—Bleomycin—melanoma	0.000291	0.00193	CcSEcCtD
Trandolapril—Agitation—Temozolomide—melanoma	0.00029	0.00193	CcSEcCtD
Trandolapril—Angioedema—Temozolomide—melanoma	0.000288	0.00192	CcSEcCtD
Trandolapril—Pancytopenia—Docetaxel—melanoma	0.000286	0.0019	CcSEcCtD
Trandolapril—Hypotension—Bleomycin—melanoma	0.000285	0.0019	CcSEcCtD
Trandolapril—Oedema—Dactinomycin—melanoma	0.000284	0.00189	CcSEcCtD
Trandolapril—Malaise—Temozolomide—melanoma	0.000284	0.00189	CcSEcCtD
Trandolapril—Vertigo—Temozolomide—melanoma	0.000283	0.00188	CcSEcCtD
Trandolapril—Infection—Dactinomycin—melanoma	0.000282	0.00188	CcSEcCtD
Trandolapril—Leukopenia—Temozolomide—melanoma	0.000282	0.00188	CcSEcCtD
Trandolapril—Neutropenia—Docetaxel—melanoma	0.000281	0.00187	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—ADAMTS20—melanoma	0.000281	0.00951	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PIGU—melanoma	0.000281	0.00951	CbGpPWpGaD
Trandolapril—Palpitations—Temozolomide—melanoma	0.000278	0.00185	CcSEcCtD
Trandolapril—Thrombocytopenia—Dactinomycin—melanoma	0.000278	0.00185	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Bleomycin—melanoma	0.000278	0.00185	CcSEcCtD
Trandolapril—Myalgia—Carmustine—melanoma	0.000278	0.00185	CcSEcCtD
Trandolapril—Chest pain—Carmustine—melanoma	0.000278	0.00185	CcSEcCtD
Trandolapril—Anxiety—Carmustine—melanoma	0.000277	0.00184	CcSEcCtD
Trandolapril—Cough—Temozolomide—melanoma	0.000275	0.00183	CcSEcCtD
Trandolapril—Paraesthesia—Bleomycin—melanoma	0.000274	0.00182	CcSEcCtD
Trandolapril—Dyspnoea—Bleomycin—melanoma	0.000272	0.00181	CcSEcCtD
Trandolapril—Anorexia—Dactinomycin—melanoma	0.000271	0.0018	CcSEcCtD
Trandolapril—Myalgia—Temozolomide—melanoma	0.000268	0.00179	CcSEcCtD
Trandolapril—Arthralgia—Temozolomide—melanoma	0.000268	0.00179	CcSEcCtD
Trandolapril—Infestation—Docetaxel—melanoma	0.000268	0.00178	CcSEcCtD
Trandolapril—Infestation NOS—Docetaxel—melanoma	0.000268	0.00178	CcSEcCtD
Trandolapril—Anxiety—Temozolomide—melanoma	0.000267	0.00178	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000266	0.00177	CcSEcCtD
Trandolapril—Oedema—Carmustine—melanoma	0.000266	0.00177	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000266	0.00177	CcSEcCtD
Trandolapril—Discomfort—Temozolomide—melanoma	0.000265	0.00176	CcSEcCtD
Trandolapril—Decreased appetite—Bleomycin—melanoma	0.000265	0.00176	CcSEcCtD
Trandolapril—Infection—Carmustine—melanoma	0.000264	0.00176	CcSEcCtD
Trandolapril—Acute coronary syndrome—Docetaxel—melanoma	0.000264	0.00176	CcSEcCtD
Trandolapril—Renal failure—Docetaxel—melanoma	0.000264	0.00175	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—CDK2—melanoma	0.000263	0.0089	CbGpPWpGaD
Trandolapril—Myocardial infarction—Docetaxel—melanoma	0.000263	0.00175	CcSEcCtD
Trandolapril—Dry mouth—Temozolomide—melanoma	0.000262	0.00175	CcSEcCtD
Trandolapril—Thrombocytopenia—Carmustine—melanoma	0.000261	0.00173	CcSEcCtD
Trandolapril—Tachycardia—Carmustine—melanoma	0.00026	0.00173	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000259	0.00172	CcSEcCtD
Trandolapril—Oedema—Temozolomide—melanoma	0.000257	0.00171	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—ARL2—melanoma	0.000257	0.0087	CbGpPWpGaD
Trandolapril—Infection—Temozolomide—melanoma	0.000255	0.0017	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000254	0.00862	CbGpPWpGaD
Trandolapril—Anorexia—Carmustine—melanoma	0.000254	0.00169	CcSEcCtD
Trandolapril—Hepatobiliary disease—Docetaxel—melanoma	0.000254	0.00169	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000253	0.00857	CbGpPWpGaD
Trandolapril—Epistaxis—Docetaxel—melanoma	0.000253	0.00168	CcSEcCtD
Trandolapril—Nervous system disorder—Temozolomide—melanoma	0.000252	0.00168	CcSEcCtD
Trandolapril—Thrombocytopenia—Temozolomide—melanoma	0.000252	0.00168	CcSEcCtD
Trandolapril—Feeling abnormal—Bleomycin—melanoma	0.000251	0.00167	CcSEcCtD
Trandolapril—Agranulocytosis—Docetaxel—melanoma	0.00025	0.00167	CcSEcCtD
Trandolapril—Skin disorder—Temozolomide—melanoma	0.00025	0.00166	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—ATM—melanoma	0.000249	0.00845	CbGpPWpGaD
Trandolapril—Hypotension—Carmustine—melanoma	0.000249	0.00165	CcSEcCtD
Trandolapril—Hyperhidrosis—Temozolomide—melanoma	0.000249	0.00165	CcSEcCtD
Trandolapril—Decreased appetite—Dactinomycin—melanoma	0.000247	0.00164	CcSEcCtD
Trandolapril—Fatigue—Dactinomycin—melanoma	0.000245	0.00163	CcSEcCtD
Trandolapril—Anorexia—Temozolomide—melanoma	0.000245	0.00163	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—SLC5A5—melanoma	0.000244	0.00828	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000244	0.00827	CbGpPWpGaD
Trandolapril—Musculoskeletal discomfort—Carmustine—melanoma	0.000242	0.00161	CcSEcCtD
Trandolapril—Urticaria—Bleomycin—melanoma	0.000242	0.00161	CcSEcCtD
Trandolapril—Rhinitis—Docetaxel—melanoma	0.000241	0.00161	CcSEcCtD
Trandolapril—Body temperature increased—Bleomycin—melanoma	0.000241	0.0016	CcSEcCtD
Trandolapril—Hepatitis—Docetaxel—melanoma	0.000241	0.0016	CcSEcCtD
Trandolapril—Insomnia—Carmustine—melanoma	0.000241	0.0016	CcSEcCtD
Trandolapril—Paraesthesia—Carmustine—melanoma	0.000239	0.00159	CcSEcCtD
Trandolapril—Pharyngitis—Docetaxel—melanoma	0.000239	0.00159	CcSEcCtD
Trandolapril—Urinary tract disorder—Docetaxel—melanoma	0.000238	0.00158	CcSEcCtD
Trandolapril—Dyspnoea—Carmustine—melanoma	0.000237	0.00158	CcSEcCtD
Trandolapril—Oedema peripheral—Docetaxel—melanoma	0.000237	0.00158	CcSEcCtD
Trandolapril—Somnolence—Carmustine—melanoma	0.000237	0.00157	CcSEcCtD
Trandolapril—Connective tissue disorder—Docetaxel—melanoma	0.000237	0.00157	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000236	0.008	CbGpPWpGaD
Trandolapril—Urethral disorder—Docetaxel—melanoma	0.000236	0.00157	CcSEcCtD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000235	0.00797	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000235	0.00796	CbGpPWpGaD
Trandolapril—Feeling abnormal—Dactinomycin—melanoma	0.000234	0.00156	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Temozolomide—melanoma	0.000234	0.00156	CcSEcCtD
Trandolapril—Insomnia—Temozolomide—melanoma	0.000233	0.00155	CcSEcCtD
Trandolapril—Gastrointestinal pain—Dactinomycin—melanoma	0.000233	0.00155	CcSEcCtD
Trandolapril—Visual impairment—Docetaxel—melanoma	0.000232	0.00154	CcSEcCtD
Trandolapril—Decreased appetite—Carmustine—melanoma	0.000231	0.00154	CcSEcCtD
Trandolapril—Paraesthesia—Temozolomide—melanoma	0.000231	0.00154	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00023	0.00778	CbGpPWpGaD
Trandolapril—Gastrointestinal disorder—Carmustine—melanoma	0.00023	0.00153	CcSEcCtD
Trandolapril—Dyspnoea—Temozolomide—melanoma	0.000229	0.00153	CcSEcCtD
Trandolapril—Somnolence—Temozolomide—melanoma	0.000229	0.00152	CcSEcCtD
Trandolapril—Erythema multiforme—Docetaxel—melanoma	0.000228	0.00151	CcSEcCtD
Trandolapril—Constipation—Carmustine—melanoma	0.000228	0.00151	CcSEcCtD
Trandolapril—Dyspepsia—Temozolomide—melanoma	0.000226	0.00151	CcSEcCtD
Trandolapril—Eye disorder—Docetaxel—melanoma	0.000225	0.0015	CcSEcCtD
Trandolapril—Abdominal pain—Dactinomycin—melanoma	0.000225	0.0015	CcSEcCtD
Trandolapril—Body temperature increased—Dactinomycin—melanoma	0.000225	0.0015	CcSEcCtD
Trandolapril—Hypersensitivity—Bleomycin—melanoma	0.000225	0.00149	CcSEcCtD
Trandolapril—Decreased appetite—Temozolomide—melanoma	0.000224	0.00149	CcSEcCtD
Trandolapril—Flushing—Docetaxel—melanoma	0.000223	0.00149	CcSEcCtD
Trandolapril—Cardiac disorder—Docetaxel—melanoma	0.000223	0.00149	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Temozolomide—melanoma	0.000222	0.00148	CcSEcCtD
Trandolapril—Fatigue—Temozolomide—melanoma	0.000222	0.00148	CcSEcCtD
Trandolapril—Constipation—Temozolomide—melanoma	0.00022	0.00146	CcSEcCtD
Trandolapril—Feeling abnormal—Carmustine—melanoma	0.000219	0.00146	CcSEcCtD
Trandolapril—Asthenia—Bleomycin—melanoma	0.000219	0.00146	CcSEcCtD
Trandolapril—Angiopathy—Docetaxel—melanoma	0.000218	0.00145	CcSEcCtD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000218	0.00739	CbGpPWpGaD
Trandolapril—Gastrointestinal pain—Carmustine—melanoma	0.000218	0.00145	CcSEcCtD
Trandolapril—Immune system disorder—Docetaxel—melanoma	0.000217	0.00145	CcSEcCtD
Trandolapril—Mediastinal disorder—Docetaxel—melanoma	0.000217	0.00144	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—RB1—melanoma	0.000216	0.00732	CbGpPWpGaD
Trandolapril—Pruritus—Bleomycin—melanoma	0.000216	0.00144	CcSEcCtD
Trandolapril—Nateglinide—PPARG—melanoma	0.000215	0.0265	CrCbGaD
Trandolapril—Arrhythmia—Docetaxel—melanoma	0.000215	0.00143	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000213	0.00722	CbGpPWpGaD
Trandolapril—Alopecia—Docetaxel—melanoma	0.000213	0.00142	CcSEcCtD
Trandolapril—Feeling abnormal—Temozolomide—melanoma	0.000212	0.00141	CcSEcCtD
Trandolapril—Mental disorder—Docetaxel—melanoma	0.000211	0.0014	CcSEcCtD
Trandolapril—Abdominal pain—Carmustine—melanoma	0.00021	0.0014	CcSEcCtD
Trandolapril—Body temperature increased—Carmustine—melanoma	0.00021	0.0014	CcSEcCtD
Trandolapril—Gastrointestinal pain—Temozolomide—melanoma	0.00021	0.0014	CcSEcCtD
Trandolapril—Malnutrition—Docetaxel—melanoma	0.00021	0.00139	CcSEcCtD
Trandolapril—Hypersensitivity—Dactinomycin—melanoma	0.000209	0.00139	CcSEcCtD
Trandolapril—ACE—Peptide hormone metabolism—IGF1—melanoma	0.000207	0.00702	CbGpPWpGaD
Trandolapril—Dysgeusia—Docetaxel—melanoma	0.000205	0.00137	CcSEcCtD
Trandolapril—Urticaria—Temozolomide—melanoma	0.000204	0.00136	CcSEcCtD
Trandolapril—Asthenia—Dactinomycin—melanoma	0.000204	0.00136	CcSEcCtD
Trandolapril—Abdominal pain—Temozolomide—melanoma	0.000203	0.00135	CcSEcCtD
Trandolapril—Body temperature increased—Temozolomide—melanoma	0.000203	0.00135	CcSEcCtD
Trandolapril—Back pain—Docetaxel—melanoma	0.000203	0.00135	CcSEcCtD
Trandolapril—Muscle spasms—Docetaxel—melanoma	0.000201	0.00134	CcSEcCtD
Trandolapril—CES1—Fluoropyrimidine Activity—TP53—melanoma	0.000199	0.00676	CbGpPWpGaD
Trandolapril—Hypersensitivity—Carmustine—melanoma	0.000196	0.0013	CcSEcCtD
Trandolapril—Diarrhoea—Dactinomycin—melanoma	0.000195	0.00129	CcSEcCtD
Trandolapril—Vomiting—Bleomycin—melanoma	0.000194	0.00129	CcSEcCtD
Trandolapril—Anaemia—Docetaxel—melanoma	0.000194	0.00129	CcSEcCtD
Trandolapril—Rash—Bleomycin—melanoma	0.000192	0.00128	CcSEcCtD
Trandolapril—Dermatitis—Bleomycin—melanoma	0.000192	0.00128	CcSEcCtD
Trandolapril—Asthenia—Carmustine—melanoma	0.000191	0.00127	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—CDKN2A—melanoma	0.00019	0.00643	CbGpPWpGaD
Trandolapril—Hypersensitivity—Temozolomide—melanoma	0.000189	0.00126	CcSEcCtD
Trandolapril—Syncope—Docetaxel—melanoma	0.000188	0.00125	CcSEcCtD
Trandolapril—Leukopenia—Docetaxel—melanoma	0.000188	0.00125	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—SLC17A5—melanoma	0.000187	0.00634	CbGpPWpGaD
Trandolapril—Palpitations—Docetaxel—melanoma	0.000185	0.00123	CcSEcCtD
Trandolapril—Asthenia—Temozolomide—melanoma	0.000185	0.00123	CcSEcCtD
Trandolapril—Loss of consciousness—Docetaxel—melanoma	0.000184	0.00123	CcSEcCtD
Trandolapril—Cough—Docetaxel—melanoma	0.000183	0.00122	CcSEcCtD
Trandolapril—Diarrhoea—Carmustine—melanoma	0.000182	0.00121	CcSEcCtD
Trandolapril—Pruritus—Temozolomide—melanoma	0.000182	0.00121	CcSEcCtD
Trandolapril—Nausea—Bleomycin—melanoma	0.000181	0.00121	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—HGF—melanoma	0.000181	0.00613	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ADAMTS13—melanoma	0.000181	0.00613	CbGpPWpGaD
Trandolapril—Vomiting—Dactinomycin—melanoma	0.000181	0.0012	CcSEcCtD
Trandolapril—Rash—Dactinomycin—melanoma	0.000179	0.00119	CcSEcCtD
Trandolapril—Myalgia—Docetaxel—melanoma	0.000178	0.00119	CcSEcCtD
Trandolapril—Arthralgia—Docetaxel—melanoma	0.000178	0.00119	CcSEcCtD
Trandolapril—Chest pain—Docetaxel—melanoma	0.000178	0.00119	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000177	0.00118	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000176	0.00597	CbGpPWpGaD
Trandolapril—Dizziness—Carmustine—melanoma	0.000176	0.00117	CcSEcCtD
Trandolapril—Diarrhoea—Temozolomide—melanoma	0.000176	0.00117	CcSEcCtD
Trandolapril—Perindopril—ABCB1—melanoma	0.000175	0.0215	CrCbGaD
Trandolapril—Dry mouth—Docetaxel—melanoma	0.000174	0.00116	CcSEcCtD
Trandolapril—Oedema—Docetaxel—melanoma	0.000171	0.00114	CcSEcCtD
Trandolapril—Dizziness—Temozolomide—melanoma	0.00017	0.00113	CcSEcCtD
Trandolapril—Infection—Docetaxel—melanoma	0.00017	0.00113	CcSEcCtD
Trandolapril—Vomiting—Carmustine—melanoma	0.000169	0.00113	CcSEcCtD
Trandolapril—Nausea—Dactinomycin—melanoma	0.000169	0.00112	CcSEcCtD
Trandolapril—Shock—Docetaxel—melanoma	0.000168	0.00112	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—CDKN1B—melanoma	0.000168	0.0057	CbGpPWpGaD
Trandolapril—Rash—Carmustine—melanoma	0.000168	0.00112	CcSEcCtD
Trandolapril—Nervous system disorder—Docetaxel—melanoma	0.000168	0.00112	CcSEcCtD
Trandolapril—Dermatitis—Carmustine—melanoma	0.000168	0.00112	CcSEcCtD
Trandolapril—Thrombocytopenia—Docetaxel—melanoma	0.000167	0.00111	CcSEcCtD
Trandolapril—Tachycardia—Docetaxel—melanoma	0.000167	0.00111	CcSEcCtD
Trandolapril—Headache—Carmustine—melanoma	0.000167	0.00111	CcSEcCtD
Trandolapril—Skin disorder—Docetaxel—melanoma	0.000166	0.00111	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	0.000164	0.00554	CbGpPWpGaD
Trandolapril—Vomiting—Temozolomide—melanoma	0.000164	0.00109	CcSEcCtD
Trandolapril—Anorexia—Docetaxel—melanoma	0.000163	0.00108	CcSEcCtD
Trandolapril—Rash—Temozolomide—melanoma	0.000162	0.00108	CcSEcCtD
Trandolapril—Dermatitis—Temozolomide—melanoma	0.000162	0.00108	CcSEcCtD
Trandolapril—Headache—Temozolomide—melanoma	0.000161	0.00107	CcSEcCtD
Trandolapril—Hypotension—Docetaxel—melanoma	0.00016	0.00106	CcSEcCtD
Trandolapril—Nausea—Carmustine—melanoma	0.000158	0.00105	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Docetaxel—melanoma	0.000156	0.00104	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—CDKN1A—melanoma	0.000155	0.00526	CbGpPWpGaD
Trandolapril—Insomnia—Docetaxel—melanoma	0.000155	0.00103	CcSEcCtD
Trandolapril—Lisinopril—ABCB1—melanoma	0.000154	0.019	CrCbGaD
Trandolapril—Cilazapril—ABCB1—melanoma	0.000154	0.019	CrCbGaD
Trandolapril—ACE—Peptide hormone metabolism—CTNNB1—melanoma	0.000154	0.00521	CbGpPWpGaD
Trandolapril—Paraesthesia—Docetaxel—melanoma	0.000154	0.00102	CcSEcCtD
Trandolapril—Nausea—Temozolomide—melanoma	0.000153	0.00102	CcSEcCtD
Trandolapril—Dyspnoea—Docetaxel—melanoma	0.000152	0.00101	CcSEcCtD
Trandolapril—Somnolence—Docetaxel—melanoma	0.000152	0.00101	CcSEcCtD
Trandolapril—Dyspepsia—Docetaxel—melanoma	0.000151	0.001	CcSEcCtD
Trandolapril—Decreased appetite—Docetaxel—melanoma	0.000149	0.000989	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Docetaxel—melanoma	0.000148	0.000983	CcSEcCtD
Trandolapril—Fatigue—Docetaxel—melanoma	0.000147	0.000981	CcSEcCtD
Trandolapril—Constipation—Docetaxel—melanoma	0.000146	0.000973	CcSEcCtD
Trandolapril—Feeling abnormal—Docetaxel—melanoma	0.000141	0.000938	CcSEcCtD
Trandolapril—Gastrointestinal pain—Docetaxel—melanoma	0.00014	0.000931	CcSEcCtD
Trandolapril—Abdominal pain—Docetaxel—melanoma	0.000135	0.0009	CcSEcCtD
Trandolapril—Body temperature increased—Docetaxel—melanoma	0.000135	0.0009	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—RPS3—melanoma	0.000135	0.00457	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—MYC—melanoma	0.000129	0.00436	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000129	0.00436	CbGpPWpGaD
Trandolapril—Hypersensitivity—Docetaxel—melanoma	0.000126	0.000838	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000124	0.0042	CbGpPWpGaD
Trandolapril—Asthenia—Docetaxel—melanoma	0.000123	0.000817	CcSEcCtD
Trandolapril—Pruritus—Docetaxel—melanoma	0.000121	0.000805	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000119	0.00404	CbGpPWpGaD
Trandolapril—Diarrhoea—Docetaxel—melanoma	0.000117	0.000779	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000117	0.00396	CbGpPWpGaD
Trandolapril—Enalapril—ABCB1—melanoma	0.000113	0.0139	CrCbGaD
Trandolapril—Dizziness—Docetaxel—melanoma	0.000113	0.000753	CcSEcCtD
Trandolapril—Vomiting—Docetaxel—melanoma	0.000109	0.000724	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000108	0.00367	CbGpPWpGaD
Trandolapril—Rash—Docetaxel—melanoma	0.000108	0.000718	CcSEcCtD
Trandolapril—Dermatitis—Docetaxel—melanoma	0.000108	0.000717	CcSEcCtD
Trandolapril—Headache—Docetaxel—melanoma	0.000107	0.000713	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000105	0.00356	CbGpPWpGaD
Trandolapril—Nausea—Docetaxel—melanoma	0.000102	0.000676	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	9.75e-05	0.0033	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PAX6—melanoma	8.6e-05	0.00291	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—HSPA5—melanoma	8.27e-05	0.0028	CbGpPWpGaD
Trandolapril—Nateglinide—ALB—melanoma	8.1e-05	0.00997	CrCbGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	5.34e-05	0.00181	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	5.01e-05	0.0017	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	4.96e-05	0.00168	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MMP1—melanoma	4.89e-05	0.00166	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	4.65e-05	0.00158	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	4.07e-05	0.00138	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGF1—melanoma	3.91e-05	0.00133	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MMP2—melanoma	3.79e-05	0.00128	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	3.78e-05	0.00128	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CXCL8—melanoma	3.15e-05	0.00107	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CTNNB1—melanoma	2.9e-05	0.000984	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	2.55e-05	0.000863	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	2.36e-05	0.000801	CbGpPWpGaD
